U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07065331) titled 'A Study of Inhaled AZD8630 in Adolescents With Asthma' on June 11.
Brief Summary: The purpose of this study is to evaluate the pharmacokinetic (PK) profile, safety, tolerability, and immunogenicity of single inhaled dose of AZD8630 administered in adolescent participants with asthma as well as the safety and performance of the dry powder inhaler.
Study Start Date: June 11
Study Type: INTERVENTIONAL
Condition:
Asthma
Intervention:
DRUG: AZD8630
Single inhaled dose of AZD8630 via dry powder inhaler.
DEVICE: Dry powder inhaler
Single inhaled dose of AZD8630 via dry powder inhaler.
Recruitment Status: RECRUITING
Sponsor: Astr...